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 Tensile forces drive a reversible fibroblast-to-
myofibroblast transition during tissue growth in
engineered clefts
Philip Kollmannsberger,1,2*† Cécile M. Bidan,2,3 John W. C. Dunlop,2‡ Peter Fratzl,2 Viola Vogel1*
Myofibroblasts orchestrate wound healing processes, and if they remain activated, they drive disease progres-
sion such as fibrosis and cancer. Besides growth factor signaling, the local extracellular matrix (ECM) and its
mechanical properties are central regulators of these processes. It remains unknown whether transforming
growth factor–b (TGF-b) and tensile forces work synergistically in up-regulating the transition of fibroblasts into
myofibroblasts and whether myofibroblasts undergo apoptosis or become deactivated by other means once
tissue homeostasis is reached. We used three-dimensional microtissues grown in vitro from fibroblasts in
macroscopically engineered clefts for several weeks and found that fibroblasts transitioned into myofibroblasts
at the highly tensed growth front as the microtissue progressively closed the cleft, in analogy to closing a
wound site. Proliferation was up-regulated at the growth front, and new highly stretched fibronectin fibers were
deposited, as revealed by fibronectin fluorescence resonance energy transfer probes. As the tissue was grow-
ing, the ECM underneath matured into a collagen-rich tissue containing mostly fibroblasts instead of myofibro-
blasts, and the fibronectin fibers were under reduced tension. This correlated with a progressive rounding of
cells from the growth front inward, with decreased a–smooth muscle actin expression, YAP nuclear trans-
location, and cell proliferation. Together, this suggests that the myofibroblast phenotype is stabilized at the
growth front by tensile forces, even in the absence of endogenously supplemented TGF-b, and reverts into a
quiescent fibroblast phenotype already 10 mm behind the growth front, thus giving rise to a myofibroblast-to-
fibroblast transition. This is the hallmark of reaching prohealing homeostasis.dv
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Throughout our lifetime, most of our tissues remodel and regrow to
adapt to changing requirements and to regenerate from damage or dis-
ease. In wound repair, myofibroblasts are responsible for wound
closure. Their transition from tissue-resident fibroblasts or other mes-
enchymal precursors (1) is promoted by soluble factors such as
transforming growth factor–b1 (TGF-b1) and by mechanical cues
(2–6). The fibroblast-to-myofibroblast transition is described as a
multifactorial process that involves enhanced force generationwith en-
larged focal adhesions and incorporation of a–smooth muscle actin
(a-SMA) into stress fibers (7, 8). Furthermore, increased contraction
of extracellular matrix (ECM) fibers can uncage TGF-b from its latent
complex and release it into themedium (9). However, little is known, at
the organ level, about the fate of myofibroblasts after successful wound
closure—whether they undergo apoptosis, become senescent, or revert
to a fibroblast phenotype. Although washing away or blocking the
action of TGF-b1 in myofibroblast two-dimensional (2D) cell cultures
is sufficient to revert the phenotype in vitro, until recently, the revers-
ibility of the myofibroblast phenotype has not been demonstrated in
animals [for review, see Van De Water et al. (6)], with one exception
in a rat liver fibrosis model (10). Pathological and persistent myofibro-
blast activation can lead to hypertrophic scars or tissue fibrosis, ulti-mately resulting in a loss of organ function (3, 6, 8, 11–13). Successful
treatment of these pathologies, aswell as proper healing and remodeling
after injury or implantation, requires that tissue homeostasis be reestab-
lished. This major clinical challenge can only be addressed by a better
understanding of how biochemical and physical cues instruct fibroblasts
to proliferate and become myofibroblasts, contract the wound site, and
deposit new ECM. Moreover, the repaired tissue must return to a quies-
cent, homeostatic state to prevent fibrotic states.
In awound site, many factors interplay, such as cell-generated forces
to contract a wound, the rigidity and composition of the ECM of the
injured tissue that is interwoven with the fibrin gel from the blood clot,
and soluble factors released by blood cells entrapped in the blood clot
and by invading cells, including fibroblasts andmacrophages. Disen-
tangling this mechanically driven growth factor–cell-matrix recipro-
city to understand how forces and ECM properties drive myofibroblast
differentiation and vice versa is difficult in a real wound model because
too many factors contribute, and in 2D cell culture models due to their
inherent limitations. The native ECM deposited by cells on flat culture
substrates is limited to a thickness of 20 to 30 mmand remains randomly
organized under static conditions (14), whereas 3D fibrous scaffolds,
such as collagen gels ormatrigels, have amuch higher fiber density than
native tissue and lack much of the biochemical complexity and remod-
eling dynamics of native tissue ECM. Although most drugs are still
screened and tested in 2D cell culture, it is well established that the drug
dose response (15) and radioresponse (16) depend on the 3D micro-
environment that the cells experience. Moreover, the long-term effects
of tissue maturation on myofibroblast differentiation (17) are poorly
understood, because existing in vitro approaches are often limited to
a few hours or days.
Here, we studied the progressively changing relationship between
cellular forces, tissuematuration, andmyofibroblast differentiation over
several weeks in an in vitro 3D microtissue model (18) that addresses1 of 10
SC I ENCE ADVANCES | R E S EARCH ART I C L Eseveral of these limitations. In this assay, de novo tissue was grown from
fibroblasts, and the cells assembled their own ECM as they were grad-
ually closing millimeter-sized concave scaffold clefts. New tissue
emerged at the growth front (19), whereas increasing tissue depth
corresponds to increasing tissue maturity as transient cellular forces
are gradually converted into a permanent tissue prestress (19). To ad-
dress the challenge outlined above, we advanced the previous assay (19)
and grew normal human dermal fibroblast (NHDF)microtissues in the
corners of polydimethylsiloxane (PDMS) scaffolds with rectangular
holes. We developed automated image analysis tools to quantify fibro-
nectin (FN) fiber stretch, proliferation, and myofibroblast differentiation
as a function of tissue age. With this approach, we aim to improve our
understanding of how tissue maturation and tension-guided cell matrix
reciprocity orchestrate the fibroblast-to-myofibroblast transition and
myofibroblast activation, as well as the transition back to a homeostatic,
quiescent state. Our ultimate aim is to apply the insights derived from
these control principles to develop novel approaches to promote healing
and remodeling in the context of regenerative therapies. o
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 RESULTS
Primary human dermal fibroblasts grow de novo
microtissues progressively closing engineered clefts
Microfabricated PDMS scaffoldswithmacroscopic square-shaped clefts
were attached to the bottomof passivated cell culturewells using spacers
(Fig. 1A and fig. S5). After seeding, fibroblasts adhered to the FN–cross-
linked scaffold surfaces, but not to the well bottom, and started to pro-
liferate until a dense monolayer had formed on all sides, including on
the vertical cleft walls. After typically 3 to 4 days, the corners of the rect-
angular clefts started to fill with a thick 3D tissue (Fig. 1B). During the
subsequent 2 to 3 weeks of culture, the tissues grew larger until they
merged, and only a round opening remained in the center of the square-
shaped scaffold clefts. This is in agreementwith earlier tissue growth studies
performed in macroscopic scaffolds with mouse preosteoblasts (18) and
human mesenchymal stromal cells (20). To characterize the architecture
of the de novo formed microtissues, we fixed the tissues after 3 weeks in
culture and stained them for actin, collagen-I (Col-I), andnuclei.We found
that both FN andCol-I were present throughout the tissue, consistent with
previous observations in osteoblasts (Fig. 1E). Actin, FN, andCol-I were all
highly polarized and aligned at the tissue-medium interface but appeared
less organized in the bulk of the more mature tissue.
Cytoskeletal tension up-regulates the volumetric growth
rate of the tissue
To investigate the role of cellular traction forces in the de novo tissue
growth, we down- or up-regulated the cytoskeletal contractility through
the supplementation of the medium by blebbistatin (10 mM) or TGF-
b1 (1 ng/ml), respectively (Fig. 1I). Under control conditions, tissue
radius (see Materials andMethods) was 344 ± 13 mm, whereas under
conditions of increased and reduced cytoskeletal tension, tissue radius
increased to 428 ± 16 mm and decreased to 298 ± 9 mm, respectively
(Fig. 1, F to I, and movie S1). This shows that the volume of the tissue
formed by NHDFs in rectangular scaffold pores as measured by the
radius depends on cytoskeletal tension.
The tissue-medium interface is high in proliferating cells and
defines the growth front
To ask whether tissue volume increases mainly by cell proliferation in
the growth front, or within the entire tissue, we supplemented the me-Kollmannsberger et al., Sci. Adv. 2018;4 : eaao4881 17 January 2018dium at day 18 with EdU (5-ethynyl-2′–deoxyuridine), which incorpo-
rates only into newly synthesized DNA (Fig. 2). Although EdU-positive
nuclei appear throughout the tissue, the density of EdU-positive cells is
highest in the growth front (Fig. 2, A to C, fig. S2, and movie S2). This
could result either fromahigher proliferation rate or fromahigher over-
all cell density in the growth front. Therefore, we performed a quanti-
tative analysis of proliferation by determining the ratio of EdU-positive
to the total number of cells as a function of tissue depth and hence
tissue age. Our results show that relative EdU intensity, and hence cell
proliferation, decreased with tissue depth (Fig. 2E). EdU incorporation
was always higher at the growth front compared to the interior, with no
significant differences between conditions, that is, control or treatment
with blebbistatin or TGF-b1 (Fig. 2F). The higher EdU incorporation at
the growth front correlatedwith a flatter andmore polarized appearance
of the cell nuclei compared to a more isotropic nuclear shape in the
tissue interior, which is known tomediate the cellular response to physi-
cal cues (21, 22). Although there was no significant difference in prolif-
eration between conditions of different cell contractility, cell density was
significantly increased in TGF-b1–treated samples (Fig. 2, G and H),
suggesting that the overall proliferation during the entire growth period
was higher.
Newly deposited FN fibers are more stretched at the growth
front compared to FN fibers in the tissue interior
Because FN fiber tensionwas shown in 2D cell culture to be up-regulated
with cytoskeletal tension (23, 24), we added fluorescence resonance
energy transfer (FRET)–labeled FN (5 mg/ml) together with a ninefold
excess of unlabeled FN to the medium of growing tissues to prevent in-
termolecular FRET, and allowed cells to incorporate the FN-FRET
probe into their ECM for the last 24 hours of growth. Thus, we only
visualize the FN fibers that got assembled in the last 24 hours (14). To be
sensitive to a large range of conformational changes, we labeled dimeric
human plasma FN with acceptors on the native cysteins in modules
FNIII7 and FNIII15, respectively, and randomlywith donors as previously
described (23–25). The batch exploited here had a donor-to-acceptor
ratio of 2.5. After this incubation period, tissueswere fixed, and 3D image
stacks of the FNmatrix in the tissues were recorded by exciting the do-
nor fluorophores and recording the emission from the donor and the
acceptor fluorophores separately (Fig. 3A). As the efficiency of FRET
decreases with increasing distance between donors and acceptors, a
low intensity ratio between acceptor and donor means that FN fibers
are on average more stretched compared to a high intensity ratio (26).
We found that the FRET intensity ratio between acceptors and donors
declined as FN fibers got progressively more stretched (Fig. 3, B to E,
and movie S3) in response to increased cytoskeletal tension, in agree-
ment with previous observations (23, 24, 26).
To quantify differences in FN fiber tension between the tissue
growth front and interior, and hence as a function of tissue age, we
calculated the 3D Euclidean distance map of the tissue volume from
the growth front. As a result, each voxel in the tissue gets assigned its
Euclidean distance to the tissue surface. We found that FN-FRET grad-
ually increased with the distance from the growth front, suggesting a
decrease of FN fiber stretch with tissue age (Fig. 3, F to H). Because this
method only detects FN fibers assembled during the last 24 hours of
exposure to FN-FRET, the results show that cells in the growth front
assemble a more stretched FN fiber network compared to cells in the
more mature interior (Fig. 3G). Regions of high FN fiber stretch coin-
cide with regions where F-actin, FN, and Col-I ECM appear highly
aligned with the growth front, as described above.2 of 10
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 Cytoskeletal tension regulates FN fiber tension in the ECM
at the growth front
We next determined whether the molecular stretch in the newly de-
posited FN fibrils in the growth front is sensitive to cytoskeletal tension
andhowthismight correlatewith the tissuegrowth rate.Whenblebbistatin
was present at lowconcentrations (10mM)during the entire growthperiod
to allow for cell proliferationwhile reducing cytoskeletal tension, the FN
fibrils at the growth front were on average less extended compared to
control conditions (Fig. 3F). In contrast and when cytoskeletal tension
was increased by supplementing the medium with TGF-b at a concen-
tration of 1 ng/ml during the entire growth period, FN fibrils weremore
stretched compared to the control. In all cases, FN was significantly
more extended close to the growth front compared to the tissue interior.
a-SMA is expressed mostly at the growth front, even
without TGF-b supplementation
Because a-SMA expression is characteristic for the more contractile
myofibroblasts, but not fibroblasts, the microtissues were grown with-
out TGF-b supplementation and stained for a-SMA (red) after fixation
and counterstained for actin with phalloidin (green). Significantly,
the growth front is enriched in a-SMA, whereas only a small number ofKollmannsberger et al., Sci. Adv. 2018;4 : eaao4881 17 January 2018a-SMA–positive cells were found to reside in the tissue interior (Fig. 4,
A to C, fig. S4, andmovie S4). Quantification of the normalized a-SMA
signal density as a function of the distance to the growth front reveals a
steep decline of a-SMA–expressing cells over the very first 10 mm be-
hind the growth front.
TGF-b1 or blebbistatin supplementations tune a-SMA
expression levels but do not affect the overall phenomenon
Because the expression of a-SMA was associated with TGF-b–induced
myofibroblast differentiation (8), we next determined whether the ob-
servation that a-SMA is mostly expressed within the first 10 mm of the
growth front depends on TGF-b stimulation by adding exogenous
TGF-b1 or blebbistatin to increase and inhibit cytoskeletal tension
and the associated pathways, respectively. The expression of a-SMA at
the growth front was significantly increased under the presence of TGF-
b1 (1 ng/ml), whereas the presence of 10 mMblebbistatin had a slight but
not statistically significant decreasing effect ona-SMAexpression (Fig. 4,
D to F). In all cases, the level of a-SMA was still significantly higher at
the growth front compared to the tissue interior. The fact that the pres-
ence of supplementedTGF-b1 cannot convert the resident fibroblasts in
the tissue interior into a myofibroblast phenotype suggests that the50
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Fig. 1. De novo microtissue growth rate increased with cytoskeletal tension. (A) Schematic of the microfabrication process used to produce thick 3D PDMS
substrates with controlled macroscopic geometry. Detailed illustrations of the fabrication process are shown in fig. S5. (B) Illustration of 3D tissue growing in the
corners of rectangular substrate pores. (C and D) Illustration of surface and interior regions and tissue dimensions. (E) Maximum intensity projection of the resulting
3D tissue containing cells (blue) and ECM (red, FN; green, Col-I; blue, nuclei). The tissue is rich in both FN and Col-I fibers. (F to H) Single slices through tissues (green,
actin; blue, nuclei) at the indicated depth in xy and xz directions, under normal conditions (left) and under conditions of inhibited (middle) and elevated (right)
cytoskeletal tension in the presence of 10 mM blebbistatin or TGF-b1 (1 ng/ml), respectively. The individual channels and an animated z fly-through are shown in
fig. S1 and movie S1, respectively. (I) Quantification of tissue radius (distance between the scaffold corner and the growth front at 40 mm of z depth) after 19 days
of growth under normal conditions and in the presence of 10 mM blebbistatin or TGF-b1 (1 ng/ml), respectively. Increased cytoskeletal tension results in increased tissue
volume. Scale bars, 50 mm. Data points indicate the tissue radius for individual tissues.3 of 10
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 stimulation of thesemicrotissues by exogenousTGF-b1 cannot override
the stimulation imposed by the reduced tensile forces compared to the
growth front, as well as by the ECM microenvironment.
YAP nuclear localization is highest at the growth front
Because the nuclear translocation of YAP is up-regulated in response to
mechanical signals and promotes cell proliferation (27, 28), we next in-
vestigated the translocation of the transcription factor YAP/TAZ from
cytoplasm to nucleus as a function of the cell distance to the growth
front. For the 3D distance analysis from the growth front, we used
4′,6-diamidino-2-phenylindole (DAPI)–stained nuclei as masks to dis-
tinguish the nuclear and cytoplasmic signals (Fig. 4,G to I, andmovie S5).
We found that the percentage of nuclear YAP signal intensity decreased
fromnearly 55% at the growth front down to about 35%within the tissue
interior, indicating a significantly larger degree of nuclear localization and
therefore activity of YAP at the growth front (Fig. 4, J to L). Upon TGF-
b1 supplementation (1 ng/ml), the YAP nuclear localization again de-
clined rapidly within the first 10 mm, and was actually lower in the tissueKollmannsberger et al., Sci. Adv. 2018;4 : eaao4881 17 January 2018interior compared to the control and the blebbistatin-treated tissues
(10 mM) (Fig. 4, J to L).DISCUSSION
Although fibroblasts in 2D cell culture can be stimulated with TGF-b1
to transition intomyofibroblasts and revert back to the fibroblast pheno-
type when TGF-b1 is washed away or by blocking the action of TGF-
b1, the reversibility of themyofibroblast phenotype has not been dem-
onstrated in animals until recently [for review, see VanDeWater et al.
(6)], with one exception in a rat liver fibrosis model (10). Even with-
out TGF-b1 supplementation, we found a high density of myofibro-
blasts in the highly tensed growth front of microtissues that were
grown in engineered clefts, whereas the tissue interior that filled the
corners contained mostly quiescent fibroblasts (Figs. 3 and 4). Further-
more, cell proliferation (Fig. 2), expression of contractile a-SMA fibers
(Fig. 4, A to F), and nuclear localization of YAP (Fig. 4, G to L) were
all significantly up-regulated along the growth front compared to theF
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Fig. 2. Spatial mapping of EdU incorporation reveals that cells preferentially proliferate in the surface growth front. (A to C) Single slices through tissues at the
indicated z depth showing EdU signals from proliferating nuclei (green) and Hoechst counterstain of all nuclei (red) for all three conditions in xy and xz directions. Scale
bars, 50 mm. The individual channels and an animated z fly-through are shown in fig. S2 and movie S2, respectively. (D) Time course of proliferation experiments. Tissues
were cultured for 19 days under normal conditions and in the presence of 10 mM blebbistatin or TGF-b1 (1 ng/ml), respectively. (E) Percentage of EdU-positive volume
compared to total nuclear volume as a function of tissue depth and age. (F) Ratio of EdU-positive cells in growth front compared to interior. (G) Nuclear volume fraction
as a measure for cell density as a function of tissue depth and age. (H) Mean nuclear volume fraction for all three conditions. Error bars indicate SEM. Data points in (F)
and (H) indicate ratios and fractions for individual tissues.4 of 10
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 interior. FN-FRET probes revealed that the newly deposited FN fibers
were significantly more stretched along the growth front compared to
the tissue interior that gradually filled up the corners and were aligned
parallel to the actin cable (Fig. 3). In Fig. 5, these differences in cell phe-
notype and matrix stretch that define “tissue maturation” are graphi-
cally summarized. Supplementation of TGF-b1 to the medium only
enhanced the phenomena seen without TGF-b supplementation but
did not change it fundamentally: TGF-b1 supplementation increased
the tissue growth rate (Fig. 1), promoted higher stretch of FN fibrils
in the growth front and in the interior (Fig. 3), increaseda-SMAexpres-
sion along the growth front and its thickness (Fig. 4), and reducednuclear
localization of YAP in the tissue interior (Fig. 4). In contrast, inhibition of
myosin-II with blebbistatin resulted in lower tissue volume (Fig. 1) and
lower FN fiber extension in ECM (Fig. 3) and had little effect on YAP
nuclear translocation compared to the control (Fig. 4).
These findings, as summarized in Fig. 5, suggest the following suc-
cession of events during tissue growth: First and directly after seeding,
fibroblasts migrate and proliferate homogeneously on the scaffold sur-
face until they colonize the entire surface. Within the first 3 days after
seeding, a dense and contractile cell monolayer forms on all surfaces of
the scaffold with a highly stretched FN-rich ECM that initially does not
grow thicker than 20 to 30 mm, as observed on other planar culture sub-
strates before (14). As time progresses (typically after 4 to 5 days), theKollmannsberger et al., Sci. Adv. 2018;4 : eaao4881 17 January 2018contractile forces acting on the scaffold walls at an angle result in a lift-
off, as observed previously (18, 19, 29), resulting in a bridging of the
opposing scaffold walls by a highly contractile cell sheet while gradu-
ally filling in the scaffold corners. Tensile force acting on the cells is
highest in the growth front, and we propose here that they drive the
transition of fibroblasts into myofibroblasts, and thus the fibroblast-to-
myofibroblast transition, even in the absence of TGF-b supplemen-
tation. Enhancing cell contractility up-regulates the tissue growth rate,
as shown here by supplementing the medium with TGF-b1 (Fig. 1),
and the same effect can be induced by decreasing the cleft angle (18).
This interpretation is in agreement with in vivo data because cyto-
skeletal tension was reported to up-regulate myosin dynamics during
Drosophila embryonic wound repair (4), whereby myosin activity is
regulated by RhoA/Rock. Also in agreement with the data, we found
previously that FN fiber tension in early ECM is up-regulated in a
RhoA-dependent manner (25).
Second, themyofibroblasts at the growth front continue to assemble
a highly stretched FN matrix that, as the tissue growth front advances,
matures underneath and gets interlaced with Col-I fibers (19). The
growth front seems to bear the major load acting on the opposing scaf-
fold walls because the cells in the maturing tissue have a more rounded
cell shape. The FN matrix deposited and remodeled by these cells in
the tissue interior was less stretched, and cells adopted a quiescent,x
y
x
z
Control Blebbistatin TGF-
A
B
C D E
F G
H
in GdnHCI solution
Fig. 3. FN fiber tension is highest in the growth front and decays as the tissue matures. (A) Time course showing the late supplementation of the medium by the
FN-FRET probes. (B) Histograms of FN-FRET ratios of FN fibers within the ECM for three different medium supplementations. The FN-FRET probe was added to the
medium 24 hours before fixing the cells. The FN-FRET ratios in solution for the same batch are also given in different concentrations of the denaturant GdnHCl (gray
lines). (C to E) Single slices through tissues at the indicated z depth showing the FN-FRET ratio for all three conditions. Scale bars, 50 mm. Notice how overall tissue
volume depends on up-regulation (TGF-b1, 1 ng/ml) or down-regulation (10 mM blebbistatin) of cell contractility. An animated z fly-through is shown in movie S3. (F) Median
FRET ratio is significantly different between all three conditions. (G) Median FN-FRET ratio was always higher in the interior compared to the growth front, with no significant
differences between the three conditions. (H) FN-FRET ratio as a function of distance to the growth front or, equivalently, tissue maturity, for all three conditions. Tissues were
cultured for 19 days. Error bars indicate SEM. Data points in (F) and (G) indicate median values and ratios for individual tissues.5 of 10
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 less proliferative phenotype with low a-SMA expression and cytosolic
localization of YAP. The presence of thicker and partially radially
oriented collagen fibers in the interior furthermore indicatesmaturation
of the tissue with increasing age (19). Because collagen rather than FN is
the major force-bearing component of mature ECM (30), these more
rigid collagen cables likely shield the FN fibers from cell-generated ten-
sion as the FN and collagen meshworks are interwoven, or because the
cells preferentially engage with the collagen integrin receptors. This,
together with the more rounded and thus less contractile fibroblasts
(Fig. 1), can account for the reduced FN fiber tension seen in the
maturing tissue interior.
Previous studies in collagen-based contractile 3D microtissues have
shownadirect connectionbetween tissue tension andgeometry as defined
by the anchor points, evident by cell and collagen fiber alignment (31), but
not FN fiber stretch (32), likely due to the presence of thick collagen
bundles. Microsurgically induced wounds in these tissues healed within
24 hours, with highly motile cells contracting the tissue and pulling new
FN fibers to close the gap (33). Also, this agrees well with our observation
of increasedmobility and FN fiber assembly at the growth front compared
to the interior (movie S6). We performed laser cutting experiments in a
previous study (19), inspired by the developmental biology literature (34).
Cutting the actin cable-like growth front caused an instantaneous nick,
which “healed” within 24 hours. Reducing the active cellular tension byKollmannsberger et al., Sci. Adv. 2018;4 : eaao4881 17 January 2018adding blebbistatin before the experiment resulted in a smaller nick angle,
indicating thepresenceof both actively generated andpermanently stored
mechanical tension at the tissue edge.
Our data show that the activation of fibroblasts into contractile,
proliferative myofibroblasts is transient and that myofibroblasts can
undergo a myofibroblast-to-fibroblast transition in the presence of
TGF-b (Fig. 4). Even without addition of exogenous TGF-b, we ob-
served expression of a-SMA in the growth region (Fig. 4), but not in
the interior at later time points. Because all cells were exposed to the
same growth medium, it is the cell-generated tissue microenvironment
asmodulated by cell-generated traction forces that drives the fibroblast-
myofibroblast-fibroblast transition. Future research has to revealwhether
this transition is driven by tension gradients alone or whether other
factors contribute as well. These factors could include switching the ex-
posure of binding sites of integrin, growth factor, or cytokines on FN
fibers by releasing fiber tension or an up-regulated presence of collagen
fibers and of other ECM components.
Our results suggest that the cells, starting from a homogeneous
population of fibroblasts, transition into contractile, proliferative, ECM-
synthesizing myofibroblasts in the growth front and revert back into
quiescent fibroblasts at later time points in the more mature tissue
interior. This is remarkable, because the fate of myofibroblasts after a
successful wound closure is still debated (3, 6, 10). Although washingControl
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Fig. 4. a-SMA intensity and YAP nuclear localization were highest in the growth front. (A to C) Single slices through tissues at the indicated locations for all three
conditions. F-actin is shown in green, and a-SMA fibers are shown in red. Individual channels are shown in fig. S3, and an animated z fly-through in movie S4. (D) Ratio
of a-SMA signal density in fibers and in background as a function of tissue depth and age shows preferential a-SMA expression on the outermost layer within 10 mm
from the tissue growth front. Addition of TGF-b1 (1 ng/ml) results in an increase of a-SMA signal, whereas blebbistatin (10 mM) reduces it. (E) Average a-SMA expression
on surface and (F) ratio of a-SMA expression between growth front and interior. (G to I) Single slices through tissues at the indicated locations showing YAP signal
(cyan) overlaid with nuclei (red) for all three conditions. Individual channels are shown in fig. S4, and an animated z fly-through is shown in movie S5. (J) Ratio of YAP
signal in nuclei over total YAP signal shows a decrease from up to 60% nuclear localization on the tissue surface to nearly 25% deeper in the tissue. Addition of TGF-b
results in a larger difference (gradient) in nuclear localization between tissue growth front and interior. (K) YAP nuclear localization in the growth front and (L) ratio of
YAP nuclear localization between growth front and interior. Tissues were cultured for 19 days. Error bars indicate SEM. Data points in (E) and (F), and (K) and (L) indicate
ratios and percentages for individual tissues. Scale bars, 50 mm.6 of 10
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 away or blocking the action of TGF-b1 in myofibroblast cultures was
sufficient to revert the phenotype in vitro (6), it was only recently shown
that not all myofibroblasts undergo apoptosis in vivo but that some
revert back to an inactive fibroblast phenotype in liver fibrosis (10, 35).
We cannot completely rule out myofibroblast apoptosis in our micro-
tissues as an alternative explanation, yet the absence of apoptotic cells
on the growth front and the low proliferation rate in the tissue interior
speak against this interpretation.
If the fibroblast-to-myofibroblast transition would be irreversible,
then there should be a higher number of myofibroblast-like compared
to fibroblast-like cells, because proliferation is much higher at the
growth front. This gradient in cell phenotype and ECMalready emerges
at earlier timepoints (fig. S6). The only other explanation ismigration of
nondifferentiated cells from outside the tissue into the interior. How-
ever, time lapse recording of the tissue dynamics (movie S6) shows a
very dynamic growth surface but a rather static interior. This indicates
enhanced FN fiber assembly at the growth front but contradicts the
presence of enhanced cell migration in the interior. Moreover, the same
FNmatrix assembled by the cells in the growth front is found a few days
later in the tissue interior (19). Therefore, a transient phenotypic change
is the only model that is consistent with our data.
Developing a mechanistic understanding of whether myofibroblasts
undergo apoptosis or revert back to a fibroblast phenotype has major
implications on how to treat progressive fibrotic diseaseswhere learning
how to revert the tissue back tohomeostasis is urgentlyneeded (3,6,10,35).
Upon tissue damage, myofibroblasts are responsible for wound repair
and closure, and excessive fibroproliferation is a common complication
after injury (36). Aberrations from normal wound healing, resulting in
prolonged inflammation, scarring, and fibrosis, present a major clinical
challenge (37). These complications are associated with expression ofKollmannsberger et al., Sci. Adv. 2018;4 : eaao4881 17 January 2018myofibroblast markers, increased contractility, and disturbed ECM re-
modeling, which are mediated by TGF-b signaling (3, 5, 9, 38). For a
wound to heal properly, the right balance of fibroblast and myofibro-
blast phenotypemust bemaintained, but strategies to efficiently control
this balance are currently lacking (8). Here, we discovered that the abil-
ity of cells to generate contractile forces is the key parameter that con-
trols the transient appearance of a myofibroblast-like phenotype and,
promoted by a proper ECM architecture and composition, its reversal
back into quiescent fibroblasts. The steepness of the gradients in ECM
architecture and composition depends on, and can be controlled by, the
macroscopic geometry of a wound or scaffold (19, 33). Although our
model system lacks the provisional fibrin matrix that fills the wound
space and gets remodeled or resorbed in a physiological scenario, the
principles we discovered still apply: Contraction of a wound requires
healthy surrounding tissue to balance the contractile force. In addition
to using scaffolds as guiding structures for ECM organization during
tissue regeneration (39), the dynamic feedback process between cells
andmatrix acting during the growthprocessmust be taken into account
to induce proper healing. The same principles apply during embryogen-
esis, where geometry-dependent patterns of tensile forces are increasingly
recognized as cues for controlling cell fate and tissue structure (40).
Our findings thus have significant implications for understanding
and controlling biological processes of growth and regeneration in
the context of wound healing, tissue engineering, development, and
stem cells.MATERIALS AND METHODS
Substrate fabrication
Master fabrication
Master structures of tissue growth substrates were made using micro-
scope projection lithography (41), summarized in fig. S5. This method
allows for fast and easy fabrication of thick master structures at a frac-
tion of the cost of standard photolithography and without the need
for clean room equipment.With careful tuning of the exposure para-
meters, resolutions down to fewmicrometers can be achieved, which
is sufficient for the large-scale features used in this study. We used a
variation of the method described by Kim et al. (42). A layer of poly-
ethylene glycol diacrylate (PEG-DA; molecular weight, 700; Sigma-
Aldrich) mixed with a photocrosslinker (Irgacure 2959, BASF) at
2% (w/v) was sandwiched between a microscopy glass slide that had
been activated with 3-(trimethoxysilyl)propyl methacrylate (Sigma-
Aldrich) and a coverglass (#1, 24 mm × 60 mm) passivated using
fluorosilane [trichloro(1H,1H,2H,2H-perfluorooctyl)silane, Sigma-
Aldrich] in vapor phase. Two standard coverslips (#1, 22 mm ×
22 mm) were used as spacers, leading to a feature thickness of about
340 mm. First, a frame was polymerized around the feature area by
covering it with a piece of opaque tape and exposing it to the light of
an ultraviolet (UV) lamp (365 nm). Subsequently, the tape was re-
moved, and the master was mounted on an inverted fluorescence mi-
croscope (Zeiss Axiovert 200m, Zeiss) with the coverslip facing the
objective, and a rectangular mask (2 mm × 2 mm) was inserted into
the field stop slider of the fluorescence pathway. Using the automated
shutter and motorized XY stage of the microscope, a regular array of
rectangular features was polymerized by illuminating the master with
the DAPI channel of themicroscope through a 5× objective (numerical
aperture, 0.12) using an exposure time of 500 ms. After exposure, the
top coverslip was carefully removed, and the remaining prepolymer
was washed off using acetone.Growth
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Fig. 5. The myofibroblast-to-fibroblast transition illustrating how the highly
tensed growth front rich in myofibroblasts drives tissue growth and how
myofibroblasts revert to quiescent fibroblasts as the tissue matures. As the
tissue grows tensed by cell contractility, and new cells and ECM are added at the
growth front in a layer-by-layer process, a gradient emerges from the growth surface
toward the tissue interior. The arrow of tissue maturation denotes the emerging gra-
dients in tissue properties over space and time from the surface to the core. In the
growth front, cells proliferate, are well spread and elongated, and deposit and stretch
an early, 2D FN-rich ECM, whereas within the tissue interior, cells are more isotropic
and embedded into a 3D Col-I–rich ECM. This gradient in ECM properties correlates
with a gradient in cell phenotype, from activated myofibroblasts in the growth front
toward a quiescent fibroblast phenotype that maintains tissue homeostasis in the interior.7 of 10
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 Microfabrication of PDMS scaffolds
To create PDMS replicas, the master with the negative features was first
passivated using fluorosilane in vapor phase. A positive stampwasmade,
passivated, and used as amaster for another negative structure in PDMS.
This secondary negative master was then passivated and used to print
the final scaffold grids. For making the scaffolds, PDMS was mixed in
the standard ratio of 10:1 and poured over the negative PDMS master,
slightly overfilling the structure to fill all gaps, and degassed at 50 bar for
30min to remove trapped air bubbles. After precuring for 6min at 80°C,
the excess PDMS was skimmed with a glass slide, and the remaining
PDMSwas cured for another 2 hours at 80°C.This proved to be themost
reliablemethod togenerateopenPDMSgridswithout residualmembranes.
After removal from the master, the substrates were stored in ethanol.
Functionalization and passivation of the PDMS scaffolds
To prepare the scaffolds for tissue growth experiments (as summarized
in fig. S5), they were first cleaned and sterilized in 70% ethanol in an
ultrasonic bath for 20 min. Subsequently, FN was covalently attached
to the surfaces of the scaffold using a heterobifunctional cross-linker
(Sulfo-SANPAH, 1mg/ml, Thermo Fisher Scientific), as described pre-
viously (43). The procedure was carried out for each side separately to
ensure homogeneous functionalization. Using optical glue NOA-61
(Norland Optical Adhesive 61, Norland) and small PDMS spacers, the
functionalized substrates were then attached to an ibidi-treated glass-
bottom dish (m-Dish, 35 mm, ibidi) that had previously been passivated
using PLL (poly-L-lysine)-g-PEG (0.1 mg/ml, SuSoS). This construction
restricted cell growth to the scaffold while allowing for imaging through
the bottom coverglass. After assembly, the culture system was incubated
withmedium at 37°C for at least 1 hour before seeding cells to equilibrate
the surface and allow air bubbles to escape from the pores.
Microtissue growth experiments
Cell culture
Primary NHDFs (passage numbers 3 to 6, Lonza) were maintained in
a–minimum essential medium supplemented with 10% fetal bovine
serum and 1% penicillin-streptomycin. For experiments, cells were
trypsinized and seeded at a density of 2 × 105 cells per substrate.
The medium for experiments was additionally supplemented with as-
corbic acid (50 mg/ml) to stimulate collagen assembly, unless indicated
otherwise. To down- or up-regulate cell contractility, we supplemen-
ted the medium with blebbistatin (10 mM, Sigma-Aldrich) or human
recombinant TGF-b1 (1 ng/ml, Invitrogen), respectively. After seeding,
medium was exchanged every 2 to 3 days during the entire experi-
ment. All cultured cells in the laboratory were routinely checked for
mycoplasma infection.
Fixation and immunofluorescence
After the end of the experiment, the scaffolds were fixed in 3% para-
formaldehyde (Thermo Fisher Scientific) for 15min and permeabilized
in 1% Triton X-100 (Sigma-Aldrich) for 20min. The actin cytoskeleton
and cell nuclei were stained with Alexa Fluor 488 phalloidin (1:1000,
A12379,ThermoFisher Scientific) andDAPI (2mg/ml,D1306, Invitrogen),
respectively. Col-I primary antibody (ab90395, Abcam plc) was added
to the medium at a dilution of 1:200 30 min before fixation to facilitate
ECM staining, as described previously (44), and counterstained with
Alexa Fluor 633 goat anti-mouse secondary antibody (A-21052, Ther-
mo Fisher Scientific) at 1:50. YAPwas stained with YAP (63.7) primary
mouse monoclonal antibody (sc-101199, Santa Cruz Biotechnology) at
1:200 and counterstainedwithAlexa Fluor 633 goat anti-mouse second-
ary antibody (A-21052, Thermo Fisher Scientific) at 1:50. a-SMA was
stained with primary mouse anti–a-SMA antibody [0.N.5] (ab18147,Kollmannsberger et al., Sci. Adv. 2018;4 : eaao4881 17 January 2018Abcam plc) at 1:100 and counterstained with Alexa Fluor 546 goat anti-
mouse secondary antibody (A-11030, Thermo Fisher Scientific) at 1:100.
After washing with phosphate-buffered saline (PBS), primary and sec-
ondary antibodies were applied for 30min each except for Col-I primary
antibody, as mentioned above.
Fabrication of the FN-FRET probe
FN was isolated from human plasma, FRET-labeled, and characterized
according to previously published protocols (24). In short, FN-DA was
double-labeled with Alexa Fluor 546 C-5 maleimide (A10258, Thermo
Fisher Scientific) as acceptor on free cysteines, and with Alexa Fluor 488
succinimidyl ester (A20100, Thermo Fisher Scientific) as donor on ly-
sines, and stored in PBS (0.5 mg/ml) at −80°C. The labeling ratio was
determined by UV absorption measurements as 3.9 acceptors and 8.8
donors permolecule, respectively. The FN-FRET probe was calibrated
as reported previously (24, 25) bymeasuring the FRET intensity ratios
upon denaturation by different concentrations of GdnHCl in solution.
For FN-FRET experiments, FN-DA was mixed with unlabeled FN at a
ratio of 1:9 to prevent intermolecular energy transfer and added to the
culturemediumat the specified timepoint at a concentrationof 50mg/ml.
Proliferation assay
EdU (Thermo Fisher Scientific) was added to the cell medium of grow-
ing tissues at 10 mM at day 18, where it was incorporated into newly
synthesized DNA during the G1/S phase of the cell cycle. Cells were fixed
after 16 hours, stained for EdU with Alexa Fluor 647 azide (A10277,
Thermo Fisher Scientific), and counterstained for chromatin using
Hoechst 33342 (H3570, Thermo Fisher Scientific) (Fig. 3A). The num-
ber of EdU-positive cells relative to the total number of cells then yielded
a readout for the probability of cells to be in the G1/S phase during the
incubation period.
Microscopy and image analysis
Confocal microscopy
Tissues were imaged on an Olympus FV1000 confocal laser scanning
microscope for FN-FRET using a 10× objective. FRET donor excitation
was at 488 nm, and detection windows were at 514 to 526 nm (donor)
and 566 to 578 nm (acceptor), with a 50/50 beam splitter dividing the
emitted light between the twodetectors.All settings (photomultiplier tube
voltage, pixel dwell time, and laser power) were kept constant across all
FRET experiments. EdU and other stainingswere imaged on a Leica TCS
SMD confocal laser scanningmicroscope using a 20× air or a 63× water-
immersion objective. Fluorophores were excited with 405-, 488-, 546-,
and 633-nm laser lines,with detectionwindows set according to the emis-
sion band of the labels. Confocal stacks for the different channels were
acquired in sequential mode tominimize cross-talk between the different
acquisition channels. Only scaffold cornerswhere tissue had formedwere
included in the analysis.
Detection of tissue boundaries and 3D age-distance map
All image and data analyses were carried out using custom-written
MATLAB scripts (MATLAB R2016a, MathWorks) on a Xeon E5-2697
v2 machine with 12 cores at 2.7 GHz and 64 GB RAM (random-access
memory). Confocal image stacks were converted from vendor-specific
formats intoMATLAB arrays using the OMEBio-Formats library (45).
Tissue orientation was determined automatically from the intensity
distribution, and stacks were rotated around the z axis such that the
scaffold was always in the top left corner. Constant background was re-
moved by finding the first maximum of the intensity histogram, sub-
tracting this value from all voxels, and setting negative intensities to
zero. The original image slices were then downscaled in the xy plane
to obtain isotropic 3D resolution. Scaffold boundaries were detected8 of 10
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 by summing up the downscaled stack in z direction, applying aGaussian
filter (size = 7, s = 3) to the result, and finding the tissue boundaries
on the top and left from the projected intensities, defined as the point
were 20% of the maximum intensity is reached. To detect the tissue
surface, the normalized cumulative sum of the stack in the z direction
was Gaussian-filtered (size = 11, s = 5), converted to a mask using a
fixed threshold of 0.12, and combinedwith the previously detected scaf-
fold walls. Any remaining holes inside the tissue volume were removed
by morphological closing. To obtain the age-distance map, the 3D
Euclidean distance map of the tissue mask from the tissue surface was
calculated, thus assigning a “tissue depth” with respect to the growth
front to each location inside the tissue. This distance map was then
divided into bins with a spacing corresponding to the z step size. Finally,
the scaffold and tissue masks, as well as the distance map, were rescaled
to the original image resolution and saved for later use. Because differ-
ences in tissue volume are difficult to assess if the tissue is larger than the
field of view, we estimated tissue size bymeasuring the tissue radius, that
is, the distance between the corner of the scaffold and the growth front,
at a constant z depth of 40 mm for all image stacks.
Determination of FN-FRET ratios in microtissues
FRETexperimentswere conducted and analyzed by adapting previously
published protocols (24, 32) for our 3Dmicrotissues. In brief, donor and
acceptor stacks were corrected for detector dark current, sensitivity, and
donor bleed-through into the acceptor channel as previously described
(32) before calculating the FRET intensity ratio (IA/ID). In addition, we
determined the chromatic aberration–induced offset of both channels in
the z direction by incorporating 100-nm TetraSpeck beads (T7279,
Thermo Fisher Scientific) into unstained tissues before fixation. After
applying a corresponding subpixel shift to the donor stack to align both
channels, the “control” FRET ratio for TetraSpeck beads remained con-
stant throughout the tissue volume. This offset correction was only per-
formed for FRETmeasurements, because the other experiments did not
involve pixel-wise intensity ratios and were therefore not sensitive to
subpixel offsets. Three-dimensional distance maps of the tissue from
the surface and from the wall were determined automatically as de-
scribed above, and resulting FRET values were correlated to distance
and tissue age on a per-voxel basis.
a-SMA expression
To determine the relative amount of a-SMA expression in different loca-
tions and between conditions, tissues were fixed and stained against
a-SMA and F-actin, and confocal Z stacks of both channels were re-
corded. Image stacks were background-corrected, and individual slices
were low-pass–filtered by convolution with a Gaussian (size = 5, s = 1)
to reduce high-frequency noise. The actin channel was automatically
thresholded using Otsu’s algorithm on individual normalized slices.
Three-dimensional distancemaps of the tissue from the surface and from
thewall were determined automatically as described above. The binarized
actin image was applied to the a-SMA stack channel as a mask to dis-
criminate signal (colocalized with F-actin fibers) and background. Any
a-SMA signal not colocalized with F-actin fibers was treated as back-
ground, because a-SMA is expected to localize at actin stress fibers rather
than in the cytoplasm. The expression of a-SMA was quantified as the
actin-colocalized a-SMA signal density (signal per actin volume) divided
by thebackgrounda-SMAsignal density (signal per backgroundvolume)
to avoid effects of cell density and actin signal strength. The results were
plotted as a function of distance to the surface.
YAP nuclear translocation
To quantify the nuclear localization of YAP, tissues were fixed and
stained against YAP using an antibody and against nuclei using DAPI.Kollmannsberger et al., Sci. Adv. 2018;4 : eaao4881 17 January 2018Image stacks were background-corrected, and individual slices were
low-pass–filtered by convolution with a Gaussian (size = 5, s = 1) to
reduce high-frequency noise. To obtain a mask of the nuclei, the DAPI
signal was separated from the background by automated thresholding
using Otsu’s algorithm on each individual slice. The same thresholding
method was applied to the images of YAP-stained tissue to obtain a
mask of the cells, because YAP is located both in the nucleus and in
the cytoplasm. Three-dimensional distance maps of the tissue from
the surface and from the wall were determined automatically as de-
scribed above. Each voxel in theYAPchannelwas categorized as nuclear,
cytoplasmic, or background depending on whether it matched both
masks (nuclei and cells), only the cell mask, or neither of the two. To
quantify the nuclear-to-cytoplasmic ratio, the YAP signal densities were
divided by each other for each distance bin.
EdU imaging
To map cell proliferation as a function of location and tissue age, EdU
was incorporated, and nuclei were stained for proliferating cells (EdU
positive) and counterstained using Hoechst (all cells). Confocal image
stacks were background-corrected, and individual slices were low-pass–
filtered by convolution with a Gaussian (size = 5, s = 1) to reduce high-
frequency noise. To obtain a mask of the nuclei, both channels were
individually separated from the background by automated thresholding
using Otsu’s algorithm on each individual slice. Three-dimensional
distance maps of the tissue from the surface and from the wall were
determined automatically as described above, but using slightly
larger Gaussian kernels to account for the more localized intensity
distribution, because only nuclei were labeled in this case. To quan-
tify the percentage of proliferating cells, the total volume of all EdU-
positive nuclei was divided by the total volume of all nuclei for each
distance bin.
Statistical analysis
All parameters were tested for differences between the three conditions
using one-way analysis of variance (ANOVA) and corrected for mul-
tiple testing using Bonferroni correction. For the data in Fig. 2F, non-
parametric ANOVA (Kruskal-Wallis) was used. Each reported assay
includes data from 8 different tissues (9 in the case of FRET) per con-
dition, as stated in the figure legends, from at least two different inde-
pendent tissue growth experiments for each condition and assay,
amounting to a total of 99 tissues analyzed. In the figures, significance
levels for differences between groups are indicated as *P < 0.05, **P <
0.01, and ***P < 0.001. All data analysis was carried out using fully auto-
mated scripts to prevent investigator bias.SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/4/1/eaao4881/DC1
fig. S1. Individual channels of images from Fig. 1, F to H.
fig. S2. Individual channels of images from Fig. 2, A to C.
fig. S3. Individual channels of images from Fig. 4, A to C.
fig. S4. Individual channels of images from Fig. 4, G to I.
fig. S5. Illustration of the scaffold fabrication method.
fig. S6. Gradients of cell phenotype and FN stretch after 11 days.
movie S1. Z stack showing actin (green) and nuclei (blue).
movie S2. Z stack showing nuclei (red) and EdU (green).
movie S3. Z stack showing color-coded FN-FRET signals.
movie S4. Z stack showing actin (green) and a-SMA (red).
movie S5. Z stack showing nuclei (red) and YAP (cyan).
movie S6. Time lapse recording of a tissue with fluorescently labeled FN.9 of 10
SC I ENCE ADVANCES | R E S EARCH ART I C L E
 o
n
 April 9, 2018
http://advances.sciencem
ag.org/
D
ow
nloaded from
 REFERENCES AND NOTES
1. V. S. LeBleu, G. Taduri, J. O’Connell, Y. Teng, V. G. Cooke, C. Woda, H. Sugimoto, R. Kalluri,
Origin and function of myofibroblasts in kidney fibrosis. Nat. Med. 19, 1047–1053 (2013).
2. B. Hinz, The role of myofibroblasts in wound healing. Curr. Res. Transl. Med. 64, 171–177
(2016).
3. K. Kis, X. Liu, J. S. Hagood, Myofibroblast differentiation and survival in fibrotic disease.
Expert Rev. Mol. Med. 13, e27 (2011).
4. A. B. Kobb, T. Zulueta-Coarasa, R. Fernandez-Gonzalez, Tension regulates myosin
dynamics during Drosophila embryonic wound repair. J. Cell Sci. 130, 689–696 (2017).
5. J. W. O’Connor, E. W. Gomez, Biomechanics of TGFb-induced epithelial-mesenchymal
transition: Implications for fibrosis and cancer. Clin. Transl. Med. 3, 23 (2014).
6. L. Van De Water, S. Varney, J. J. Tomasek, Mechanoregulation of the myofibroblast in
wound contraction, scarring, and fibrosis: Opportunities for new therapeutic intervention.
Adv. Wound Care (New Rochelle) 2, 122–141 (2013).
7. F. Guo, D. E. Carter, A. Leask, miR-218 regulates focal adhesion kinase–dependent TGFb
signaling in fibroblasts. Mol. Biol. Cell 25, 1151–1158 (2014).
8. B. Hinz, S. H. Phan, V. J. Thannickal, M. Prunotto, A. Desmoulière, J. Varga, O. De Wever,
M. Mareel, G. Gabbiani, Recent developments in myofibroblast biology: Paradigms for
connective tissue remodeling. Am. J. Pathol. 180, 1340–1355 (2012).
9. F. Klingberg, M. L. Chow, A. Koehler, S. Boo, L. Buscemi, T. M. Quinn, M. Costell,
B. A. Alman, E. Genot, B. Hinz, Prestress in the extracellular matrix sensitizes latent
TGF-b1 for activation. J. Cell Biol. 207, 283–297 (2014).
10. T. Kisseleva, M. Cong, Y. Paik, D. Scholten, C. Jiang, C. Benner, K. Iwaisako, T. Moore-Morris,
B. Scott, H. Tsukamoto, S. M. Evans, W. Dillmann, C. K. Glass, D. A. Brenner,
Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis.
Proc. Natl. Acad. Sci. U.S.A. 109, 9448–9453 (2012).
11. C. Huang, R. Ogawa, Fibroproliferative disorders and their mechanobiology.
Connect. Tissue Res. 53, 187–196 (2012).
12. P. Kong, P. Christia, N. G. Frangogiannis, The pathogenesis of cardiac fibrosis.
Cell. Mol. Life Sci. 71, 549–574 (2014).
13. N. Nakagawa, J. S. Duffield, Myofibroblasts in fibrotic kidneys. Curr. Pathobiol. Rep. 1,
189–198 (2013).
14. K. E. Kubow, E. Klotzsch, M. L. Smith, D. Gourdon, W. C. Little, V. Vogel, Crosslinking of
cell-derived 3D scaffolds up-regulates the stretching and unfolding of new
extracellular matrix assembled by reseeded cells. Integr. Biol. (Camb.) 1, 635–648
(2009).
15. D. E. Ingber, Reverse engineering human pathophysiology with organs-on-chips. Cell
164, 1105–1109 (2016).
16. J.-M. Nam, Y. Onodera, M. J. Bissell, C. C. Park, Breast cancer cells in three-dimensional
culture display an enhanced radioresponse after coordinate targeting of integrin
a5b1 and fibronectin. Cancer Res. 70, 5238–5248 (2010).
17. C. X. Li, N. P. Talele, S. Boo, A. Koehler, E. Knee-Walden, J. L. Balestrini, P. Speight, A. Kapus,
B. Hinz, MicroRNA-21 preserves the fibrotic mechanical memory of mesenchymal
stem cells. Nat. Mater. 16, 379−389 (2017).
18. C. M. Bidan, K. P. Kommareddy, M. Rumpler, P. Kollmannsberger, Y. J. M. Bréchet, P. Fratzl,
J. W. C. Dunlop, How linear tension converts to curvature: Geometric control of bone
tissue growth. PLOS ONE 7, e36336 (2012).
19. C. M. Bidan, P. Kollmannsberger, V. Gering, S. Ehrig, P. Joly, A. Petersen, V. Vogel, P. Fratzl,
J. W. C. Dunlop, Gradual conversion of cellular stress patterns into pre-stressed matrix
architecture during in vitro tissue growth. J. R. Soc. Interface 13, 20160136 (2016).
20. M. Herklotz, M. C. Prewitz, C. M. Bidan, J. W. C. Dunlop, P. Fratzl, C. Werner, Availability of
extracellular matrix biopolymers and differentiation state of human mesenchymal
stem cells determine tissue-like growth in vitro. Biomaterials 60, 121–129 (2015).
21. S. Cho, J. Irianto, D. E. Discher, Mechanosensing by the nucleus: From pathways to scaling
relationships. J. Cell Biol. 216, 305–315 (2017).
22. K. N. Dahl, A. J. S. Ribeiro, J. Lammerding, Nuclear shape, mechanics, and
mechanotransduction. Circ. Res. 102, 1307–1318 (2008).
23. G. Baneyx, L. Baugh, V. Vogel, Coexisting conformations of fibronectin in cell culture
imaged using fluorescence resonance energy transfer. Proc. Natl. Acad. Sci. U.S.A. 98,
14464–14468 (2001).
24. M. L. Smith, D. Gourdon, W. C. Little, K. E. Kubow, R. A. Eguiluz, S. Luna-Morris, V. Vogel,
Force-induced unfolding of fibronectin in the extracellular matrix of living cells.
PLOS Biol. 5, e268 (2007).
25. G. Baneyx, L. Baugh, V. Vogel, Fibronectin extension and unfolding within cell matrix
fibrils controlled by cytoskeletal tension. Proc. Natl. Acad. Sci. U.S.A. 99, 5139–5143 (2002).
26. W. C. Little, M. L. Smith, U. Ebneter, V. Vogel, Assay to mechanically tune and optically
probe fibrillar fibronectin conformations from fully relaxed to breakage. Matrix Biol. 27,
451–461 (2008).
27. G. Nardone, J. Oliver-De La Cruz, J. Vrbsky, C. Martini, J. Pribyl, P. Skládal, M. Pešl,
G. Caluori, S. Pagliari, F. Martino, Z. Maceckova, M. Hajduch, A. Sanz-Garcia, N. M. Pugno,
G. B. Stokin, G. Forte, YAP regulates cell mechanics by controlling focal adhesion
assembly. Nat. Commun. 8, 15321 (2017).Kollmannsberger et al., Sci. Adv. 2018;4 : eaao4881 17 January 201828. T. Panciera, L. Azzolin, M. Cordenonsi, S. Piccolo, Mechanobiology of YAP and TAZ in
physiology and disease. Nat. Rev. Mol. Cell Biol. 18, 758–770 (2017).
29. T. Yamashita, P. Kollmannsberger, K. Mawatari, T. Kitamori, V. Vogel, Cell sheet mechanics:
How geometrical constraints induce the detachment of cell sheets from concave
surfaces. Acta Biomater. 45, 85–97 (2016).
30. K. E. Kubow, R. Vukmirovic, L. Zhe, E. Klotzsch, M. L. Smith, D. Gourdon, S. Luna, V. Vogel,
Mechanical forces regulate the interactions of fibronectin and collagen I in
extracellular matrix. Nat. Commun. 6, 8026 (2015).
31. W. R. Legant, A. Pathak, M. T. Yang, V. S. Deshpande, R. M. McMeeking, C. S. Chen,
Microfabricated tissue gauges to measure and manipulate forces from 3D microtissues.
Proc. Natl. Acad. Sci. U.S.A. 106, 10097–10102 (2009).
32. W. R. Legant, C. S. Chen, V. Vogel, Force-induced fibronectin assembly and matrix
remodeling in a 3D microtissue model of tissue morphogenesis. Integr. Biol. (Camb.) 4,
1164–1174 (2012).
33. M. S. Sakar, J. Eyckmans, R. Pieters, D. Eberli, B. J. Nelson, C. S. Chen, Cellular forces and
matrix assembly coordinate fibrous tissue repair. Nat. Commun. 7, 11036 (2016).
34. P. Campinho, M. Behrndt, J. Ranft, T. Risler, N. Minc, C.-P. Heisenberg, Tension-oriented
cell divisions limit anisotropic tissue tension in epithelial spreading during zebrafish
epiboly. Nat. Cell Biol. 15, 1405–1414 (2013).
35. S. Lepreux, A. Desmoulière, Human liver myofibroblasts during development and
diseases with a focus on portal (myo)fibroblasts. Front. Physiol. 6, 173 (2015).
36. M. Junkin, S. L. Leung, S. Whitman, C. C. Gregorio, P. K. Wong, Cellular self-organization by
autocatalytic alignment feedback. J. Cell Sci. 124, 4213–4220 (2011).
37. S. Guo, L. A. DiPietro, Factors affecting wound healing. J. Dent. Res. 89, 219–229 (2010).
38. A. Biernacka, M. Dobaczewski, N. G. Frangogiannis, TGF-b signaling in fibrosis.
Growth Factors 29, 196–202 (2011).
39. A. Cipitria, C. Lange, H. Schell, W. Wagermaier, J. C. Reichert, D. W. Hutmacher, P. Fratzl,
G. N. Duda, Porous scaffold architecture guides tissue formation. J. Bone Miner. Res.
27, 1275–1288 (2012).
40. C. J. Chan, C.-P. Heisenberg, T. Hiiragi, Coordination of morphogenesis and cell-fate
specification in development. Curr. Biol. 27, R1024–R1035 (2017).
41. J. C. Love, D. B. Wolfe, H. O. Jacobs, G. M. Whitesides, Microscope projection
photolithography for rapid prototyping of masters with micron-scale features for use in
soft lithography. Langmuir 17, 6005–6012 (2001).
42. P. Kim, H. E. Jeong, A. Khademhosseini, K. Y. Suh, Fabrication of non-biofouling
polyethylene glycol micro- and nanochannels by ultraviolet-assisted irreversible sealing.
Lab Chip 6, 1432–1437 (2006).
43. B. Trappmann, J. E. Gautrot, J. T. Connelly, D. G. T. Strange, Y. Li, M. L. Oyen, M. A. C. Stuart,
H. Boehm, B. Li, V. Vogel, J. P. Spatz, F. M. Watt, W. T. S. Huck, Extracellular-matrix
tethering regulates stem-cell fate. Nat. Mater. 11, 642–649 (2012).
44. T. O. Ihalainen, L. Aires, F. A. Herzog, R. Schwartlander, J. Moeller, V. Vogel, Differential
basal-to-apical accessibility of lamin A/C epitopes in the nuclear lamina regulated by
changes in cytoskeletal tension. Nat. Mater. 14, 1252–1261 (2015).
45. M. Linkert, C. T. Rueden, C. Allan, J.-M. Burel, W. Moore, A. Patterson, B. Loranger, J. Moore,
C. Neves, D. MacDonald, A. Tarkowska, C. Sticco, E. Hill, M. Rossner, K. W. Eliceiri,
J. R. Swedlow, Metadata matters: Access to image data in the real world. J. Cell Biol. 189,
777–782 (2010).
Acknowledgments
Funding: Parts of the research leading to these results have received funding from the
European Union Seventh Framework Programme (FP7/2007–2013) under grant agreement
no. 327065 (P.K.), a European Research Council (ERC) Advanced Grant (233157) from
the ERC (V.V.), the Swiss Science Foundation through project CR32I3-156931 (V.V.), and
from ETH Zurich. Author contributions: P.K., C.M.B., J.W.C.D., P.F., and V.V. designed
research. P.K., C.M.B., and J.W.C.D. developed experimental methods and data analysis.
P.K. conducted experiments and analyzed data. All authors discussed the results. P.K. and
V.V. wrote the manuscript. Competing interests: The authors declare that they have no
competing interests. Data and materials availability: All data needed to evaluate the
conclusions in the paper are present in the paper and/or the Supplementary Materials.
Additional data related to this paper may be requested from the authors. All data and the
MATLAB code to produce the plots from the data are available for download from the
author homepage.
Submitted 26 July 2017
Accepted 11 December 2017
Published 17 January 2018
10.1126/sciadv.aao4881
Citation: P. Kollmannsberger, C. M. Bidan, J. W. C. Dunlop, P. Fratzl, V. Vogel, Tensile forces
drive a reversible fibroblast-to-myofibroblast transition during tissue growth in engineered
clefts. Sci. Adv. 4, eaao4881 (2018).10 of 10
engineered clefts
Tensile forces drive a reversible fibroblast-to-myofibroblast transition during tissue growth in
Philip Kollmannsberger, Cécile M. Bidan, John W. C. Dunlop, Peter Fratzl and Viola Vogel
DOI: 10.1126/sciadv.aao4881
 (1), eaao4881.4Sci Adv 
ARTICLE TOOLS http://advances.sciencemag.org/content/4/1/eaao4881
MATERIALS
SUPPLEMENTARY http://advances.sciencemag.org/content/suppl/2018/01/12/4.1.eaao4881.DC1
REFERENCES
http://advances.sciencemag.org/content/4/1/eaao4881#BIBL
This article cites 45 articles, 13 of which you can access for free
PERMISSIONS http://www.sciencemag.org/help/reprints-and-permissions
Terms of ServiceUse of this article is subject to the 
registered trademark of AAAS.
is aScience Advances Association for the Advancement of Science. No claim to original U.S. Government Works. The title 
York Avenue NW, Washington, DC 20005. 2017 © The Authors, some rights reserved; exclusive licensee American 
(ISSN 2375-2548) is published by the American Association for the Advancement of Science, 1200 NewScience Advances 
 o
n
 April 9, 2018
http://advances.sciencem
ag.org/
D
ow
nloaded from
 
